Purple Biotech says new U.S. patent allowance strengthens CAPTN-3 platform protection
Purple Biotech (PPBT) announced a U.S. patent allowance that strengthens protection for its CAPTN-3 modular platform for next-generation multispecific antibodies.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.